J&J's Kenvue consumer health business prepares for stock IPO
Johnson & Johnson’s Kenvue consumer health business is preparing for an initial public offering of more than 151 million shares of its stock
By Associated Press
Published - Apr 25, 2023, 08:33 AM ET
Last Updated - Jun 22, 2023, 04:12 AM EDT
Johnson & Johnson’s Kenvue consumer health business is preparing for an initial public offering of more than 151 million shares.
The health care giant said late Monday that the per-share IPO price for Kenvue Inc. should range between $20 and $23. J&J said Kenvue has launched a road show for its IPO. That involves the company talking to potential investors ahead of the offering.
The consumer health business sells well-known products like Band-Aids, Listerine and over-the-counter medicines such as Tylenol. J&J has said it expects an IPO by the end of the year.
J&J announced in late 2021 that it was splitting its consumer health division from the pharmaceutical and medical device divisions in a bid to make each more nimble.
